Pediapharm Inc.

Pediapharm Inc.
Stock Exchange Toronto Ventures Stock Exchange
EPS
CAD0.03
Market Cap
CAD30.42 M
Shares Outstanding
77.99 M
Public Float
37.88 M

Profile

Address
1, Place du Commerce
Verdun Québec H3E 1A2
Canada
Employees -
Website http://www.pedia-pharm.com
Updated 09/14/2018
Pediapharm Inc. operates as a pediatric specialty pharmaceutical company. It distributes prescription medicines that are used to treat pathological conditions, which primarily affect children; and commercializes non-prescription products, such as non-prescription drugs, medical devices, and diagnostic products that fulfill unmet medical needs of children. The company portfolio includes NYDA for the treatment of head lice; EpiCeram, a skin barrier repair emulsion for the treatment of dermatitis; KoolEffect Patch, a patch with a hydrogel layer that reduces the skin temperature for an extended period of time when put in direct contact with the skin; Vapolyptus Patch to facilitate children breathe better during bedtime; Tips Haler used to maximize deep deposition of the medication in the lungs.

Financials

View All

Sylvain Chrétien
President, Chief Executive Officer & Director
Pierre Lapalme
Chairman